BIOA Competitors & Alternatives

Compare BioAge Labs, Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BIOA

Main Stock
$22.78
Tradestie Score
55
Market Cap
$212.23M
Revenue Growth
0.9%
Analyst Upside
+117.3%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
XERS Xeris Biopharma Holdings, Inc. Common Stock
$8.28
$1.29B 119.1 61 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$18.81
$1.25B 11.3 55 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$25.01
$1.14B 196.0 57 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$35.02
$1.11B 17.1 54 Compare
CRON Cronos Group Inc. Common Share
$2.75
$1.02B - 62 Compare
ZBIO Zenas BioPharma, Inc. Common Stock
$28.78
$931.48M - 61 Compare
BCAX Bicara Therapeutics Inc. Common Stock
$28.10
$906.29M - 61 Compare
MBX MBX Biosciences, Inc. Common Stock
$56.59
$800.41M - 52 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.04
$711.32M - 52 Compare

Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry